Search research articles
Contact Us
Filters
Showing results (1-10 of 4) with videos related to
Page
of 1
Sort By:
The Israel Medical Association Journal : IMAJ
|
December 3, 2014
Hereditary angioedema and autoimmunity
Paola Triggianese, Maria D Guarino, Eleonora Ballanti, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)
|
November 25, 2003
GM-CSF and pregnancy: evidence of significantly reduced blood concentrations in unexplained recurrent abortion efficiently reverted by intravenous immunoglobulin treatment
Roberto Perricone, Caterina De Carolis, Roberto Giacomelli, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)
|
October 21, 2004
Anti-thyroid antibodies and antiphospholipid syndrome: evidence of reduced fecundity and of poor pregnancy outcome in recurrent spontaneous aborters
Caterina De Carolis, Elisabetta Greco, Maria D Guarino, et al.
The Lancet. Haematology
|
March 22, 2026
Oral deucrictibant for prophylaxis of hereditary angioedema attacks (CHAPTER-1): primary analysis of a randomised, double-blind, placebo-controlled, phase 2 trial
Emel Aygören-Pürsün, Marcin Stobiecki, Anna Valerieva, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 4) with videos related to
Sort By:
Page
of 1
The Israel Medical Association Journal : IMAJ
|
December 3, 2014
Hereditary angioedema and autoimmunity
Paola Triggianese, Maria D Guarino, Eleonora Ballanti, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)
|
November 25, 2003
GM-CSF and pregnancy: evidence of significantly reduced blood concentrations in unexplained recurrent abortion efficiently reverted by intravenous immunoglobulin treatment
Roberto Perricone, Caterina De Carolis, Roberto Giacomelli, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)
|
October 21, 2004
Anti-thyroid antibodies and antiphospholipid syndrome: evidence of reduced fecundity and of poor pregnancy outcome in recurrent spontaneous aborters
Caterina De Carolis, Elisabetta Greco, Maria D Guarino, et al.
The Lancet. Haematology
|
March 22, 2026
Oral deucrictibant for prophylaxis of hereditary angioedema attacks (CHAPTER-1): primary analysis of a randomised, double-blind, placebo-controlled, phase 2 trial
Emel Aygören-Pürsün, Marcin Stobiecki, Anna Valerieva, et al.
Page
of 1